Combination of tulmimetostat and PD-1 blockade for patients with advanced non-small cell lung cancer who progressed from first or second line of treatments

Authors

• Daniel Sanghoon Shin
• Tianhong Li
• Garth Strohbehn
• Paul Cheng
• Kevin Zheng
• Hannah Tavalire, Advocate Health - MidwestFollow
• et al

Recommended Citation

Shin DS, Li T, Strohbehn G, et al. Combination of tulmimetostat and PD-1 blockade for patients with advanced non–small cell lung cancer who progressed from first or second line of treatments. Journal of Clinical Oncology. 2026/06/01 2026;44(16_suppl):TPS8664-TPS8664. doi:10.1200/JCO.2026.44.16_suppl.TPS8664

Document Type

Abstract